Insider trades
Justin A. Renz, CFO of Zevra Therapeutics ZVRA, has filed 0 purchases and 12 sales on the open market. The latest trade was on 03/18.
Justin A. Renz
CFO
- Company
- Zevra Therapeutics ZVRA
- First filing
- 23/01/06
- Trades
- 21 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- No record
- Last trade
- 03/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ArdelyxARDX | Open-market sale | 25/08/21 | 25/08/25 | 7,037 sh | $5.93 | $41,729.41 | −1.7% |
ArdelyxARDX | Open-market sale | 25/05/20 | 25/05/22 | 7,218 sh | $4.08 | $29,449.44 | −1.7% |
ArdelyxARDX | Open-market sale | 25/02/20 | 25/02/21 | 5,171 sh | $5.62 | $29,061.02 | −1.8% |
ArdelyxARDX | Open-market sale | 24/11/20 | 24/11/22 | 5,260 sh | $4.79 | $25,195.4 | −1.8% |
ArdelyxARDX | Open-market sale | 24/08/20 | 24/08/22 | 5,289 sh | $5.86 | $30,993.54 | −1.8% |
ArdelyxARDX | Open-market sale | 24/05/21 | 24/05/23 | 5,167 sh | $7.81 | $40,354.27 | −1.7% |
ArdelyxARDX | Open-market sale | 24/02/20 | 24/02/22 | 5,341 sh | $8.75 | $46,733.75 | −1.7% |
ArdelyxARDX | Open-market sale10b5-1 plan | 23/12/26 | 23/12/28 | 225,000 sh | $6.36 | $1,431,000 | −55.2% |
ArdelyxARDX | Open-market sale | 23/11/20 | 23/11/22 | 2,873 sh | $4.36 | $12,526.28 | −0.9% |
ArdelyxARDX | Open-market sale | 23/08/21 | 23/08/23 | 2,884 sh | $3.55 | $10,238.2 | −0.9% |
ArdelyxARDX | Open-market sale | 23/05/23 | 23/05/25 | 2,873 sh | $3.65 | $10,486.45 | −0.8% |
ArdelyxARDX | Open-market sale | 23/02/21 | 23/02/24 | 3,439 sh | $3.00 | $10,317 | −1.0% |
